Vimarsana
Biggest News Aggregation in the World

Page 15 - Commodore Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Commodore Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Commodore Capital Today - Breaking & Trending Today

Alpine Immune Sciences (NASDAQ:ALPN) Reaches New 1-Year High at $10.98 - Vimarsana News

Alpine Immune Sciences (NASDAQ:ALPN) Reaches New 1-Year High at $10.98

Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) shares reached a new 52-week high on Monday . The company traded as high as $10.98 and last traded at $10.86, with a volume of 44021 shares trading hands. The stock had previously closed at $10.53. Wall Street Analyst Weigh In A number of research analysts recently […]

Ambrx Biopharma (NYSE:AMAM) Shares Up 6.2% - Vimarsana News

Ambrx Biopharma (NYSE:AMAM) Shares Up 6.2%

Shares of Ambrx Biopharma Inc. (NYSE:AMAM – Get Rating) shot up 6.2% on Tuesday . The company traded as high as $14.96 and last traded at $14.88. 257,564 shares were traded during trading, a decline of 92% from the average session volume of 3,041,147 shares. The stock had previously closed at $14.01. Wall Street Analyst […]

Allakos (NASDAQ:ALLK) Upgraded to "Buy" at Jefferies Financial Group - Vimarsana News

Allakos (NASDAQ:ALLK) Upgraded to "Buy" at Jefferies Financial Group

Jefferies Financial Group upgraded shares of Allakos (NASDAQ:ALLK – Get Rating) from a hold rating to a buy rating in a research note released on Thursday, The Fly reports. Jefferies Financial Group currently has $9.00 price target on the stock, up from their prior price target of $6.00. Other analysts have also issued research reports […]

BELLUS Health (NASDAQ:BLU) Rating Lowered to Market Perform at Lifesci Capital - Vimarsana News

BELLUS Health (NASDAQ:BLU) Rating Lowered to Market Perform at Lifesci Capital

Lifesci Capital lowered shares of BELLUS Health (NASDAQ:BLU – Get Rating) from an outperform rating to a market perform rating in a report released on Tuesday morning, Marketbeat.com reports. Several other analysts have also recently weighed in on the company. Evercore ISI cut BELLUS Health to an outperform rating in a report on Tuesday. HC […]

Source: wkrb13.com
Abivax reports 2022 financial results and operations update - Vimarsana News

Abivax reports 2022 financial results and operations update

EQS-News: ABIVAX / Key word: Annual Results Abivax reports 2022 financial results and operations update 19.04.2023 / 21:00 CET/CEST The issuer is solely responsible for the... | April 19, 2023